Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Sphingolipid metabolism contributes to sexual dimorphism in COPD pathogenesis
Elisabetta Granato, Xiaoyun Wang, Yun Zhang, Joselyn Rojas-Quintero, Ida Cerqua, Scott A. Ochsner, Jeff Thomas Kue, Luca Cecchetto, Maor Sauler, Farrah Kheradmand, Joshua Malo, Fiorentina Roviezzo, Irina Petrache, Francesca Polverino
Elisabetta Granato, Xiaoyun Wang, Yun Zhang, Joselyn Rojas-Quintero, Ida Cerqua, Scott A. Ochsner, Jeff Thomas Kue, Luca Cecchetto, Maor Sauler, Farrah Kheradmand, Joshua Malo, Fiorentina Roviezzo, Irina Petrache, Francesca Polverino
View: Text | PDF
Research Article Inflammation Pulmonology

Sphingolipid metabolism contributes to sexual dimorphism in COPD pathogenesis

  • Text
  • PDF
Abstract

Sex-specific mechanisms in chronic obstructive pulmonary disease (COPD) remain poorly defined. Sphingolipids are bioactive mediators that regulate airway epithelial integrity, inflammation, and bronchial smooth muscle tone, and their dysregulation contributes to airway hyperresponsiveness. We tested whether sphingolipid metabolism is regulated by sex in COPD. Lung tissue and paired plasma from female and male never-smoking controls, ever-smoking controls, and individuals with COPD were analyzed for sphingolipid enzyme expression and metabolite levels. Bronchial rings from mice and human bronchial smooth muscle cells (HBSMCs) were exposed to estradiol or cigarette smoke extract (CSE) with and without ceramidase or sphingosine kinase inhibitors. Expression of sphingolipid regulators ASAH1 and ORMDL3 was increased in COPD airways, significantly higher in women, and correlated with airway smooth muscle remodeling. Plasma from women with COPD showed increased sphingosine-1-phosphate (S1P), whereas men exhibited higher ceramide levels. Female mice displayed greater CSE-induced bronchial reactivity, attenuated by sphingosine kinase inhibition. In male donor HBSMCs, estradiol increased ASAH1, ORMDL3, S1P, and smooth muscle protein expression and enhanced contractility. CSE further augmented molecular responses in estradiol-treated cells but reduced collagen gel contraction, whereas ceramidase inhibition attenuated estradiol-dependent effects. These findings suggest that estrogen-dependent alterations in sphingolipid metabolism contribute to airway hyperreactivity and remodeling in women with COPD.

Authors

Elisabetta Granato, Xiaoyun Wang, Yun Zhang, Joselyn Rojas-Quintero, Ida Cerqua, Scott A. Ochsner, Jeff Thomas Kue, Luca Cecchetto, Maor Sauler, Farrah Kheradmand, Joshua Malo, Fiorentina Roviezzo, Irina Petrache, Francesca Polverino

×

Figure 8

Effects of cigarette smoke and estradiol on contractility and scratch-wound closure in male-donor HBSMCs.

Options: View larger image (or click on image) Download as PowerPoint
Effects of cigarette smoke and estradiol on contractility and scratch-wo...
(A) Representative sequential images of cell plates with type I collagen mixed with human male–derived HBSMC “pellets” (2 × 105) exposed to carbachol. (B and C) Tracings of kinetics of differential change in measurement of the cell pellets in cm (DTcm) following incubation with vehicle (carbachol only), 2% CSE, 0.25 μM estradiol (E), and/or 10 μM OEA. (D) Representative images with tracings of edges of male-derived HBSMCs (2 × 105 cells) after generation of a linear scratch wound. (E and F) Kinetics of change in the wound area or scratch gap following incubation with vehicle (media only), 2% CSE, 0.25 μM estradiol (E), and/or 10 μM OEA. Panels B and C and panels E and F, respectively, display selected treatment groups from the same contraction and scratch experiments. The 2% CSE and estradiol + 2% CSE groups are included in both panels to facilitate comparisons with different treatment groups. Thus, these groups are intentionally duplicated across panels and do not represent independent experiments. ANOVA of repeated measures (P < 0.001) followed by pairwise multiple comparisons using Bonferroni’s t test. *P < 0.05; ***P < 0.001 versus indicated group (n = 3–6 per group per time point).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts